Antiphospholipid Antibodies Linked to Future CV Events Antiphospholipid Antibodies Linked to Future CV Events
The study raises the possibility of one day treating the immune system in some individuals for the prevention and treatment of cardiovascular disease, researchers suggest.Medscape Medical News
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: Cardiology News Source Type: news
More News: Antiphospholipid Syndrome | Cardiology | Cardiovascular | Heart | Hughes Syndrome | Internal Medicine | Study